TARA BEGAY: Open Payments
NPI 1962890277 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 25 payments from 9 companies in 2025. Trend: 2023 $3,083 · 2024 $1,202 · 2025 $658
Food & beverage: $543Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $298 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| ViiV Healthcare Company | 4 | $111 |
| Napo Pharmaceuticals Inc | 3 | $47 |
| Novo Nordisk Inc | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: SPRAVATO, APRETUDE, Mytesi, CABENUVA, DOVATO, Yeztugo, Biktarvy, Ozempic.
Industry payments across AZ — which companies pay providers there.
